StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
13
Publishing Date
2022 - 03 - 21
1
2022 - 03 - 14
1
2022 - 03 - 09
1
2022 - 03 - 07
1
2022 - 03 - 03
1
2022 - 02 - 28
1
2022 - 02 - 07
1
2022 - 01 - 05
2
2022 - 01 - 04
1
2021 - 12 - 15
1
2021 - 12 - 14
1
2021 - 12 - 13
1
Sector
Health technology
13
Tags
Als
13
Animal
4
Antibody
6
Antiviral
11
Cancer
6
Ceo
5
Clearance
8
Collaboration
9
Conference
33
Congress
6
Covid
20
Depression
4
Disease
10
Drug
12
Enroll
7
Events
10
Fda
12
Fibromyalgia
31
Financial
6
Financial results
5
Heart
6
Immunotherapy
4
International
11
Kidney
6
License
7
Major depressive disorder
5
Management
14
Meeting
8
Migraine
8
Monkeypox
7
N/a
199
Nasdaq
10
Offering
11
Oxytocin
11
Patent
6
Pharm-country
31
Pharmaceuticals
133
Phase 3
10
Positive
12
Potential
16
Preclinical
6
Presentation
28
Publication
6
Research
24
Results
36
Sars-cov-2
8
Smallpox
8
Study
24
T-cell
5
Technology
5
Tnx-102
18
Tnx-1500
15
Tnx-1900
12
Tnx-2900
5
Tnx-601
7
Tnx-801
6
Topline
6
Treatment
29
Trial
14
Vaccine
26
Entities
3m company
11
Abbott laboratories
7
Acadia pharmaceuticals inc.
9
Actinium pharmaceuticals, inc.
5
Adamis pharmaceuticals corporation
5
Adial pharmaceuticals, inc
5
Aerie pharmaceuticals, inc.
6
Albemarle corporation
8
Algernon pharmaceuticals inc.
8
Alstom
12
Ampio pharmaceuticals, inc.
6
Amylyx pharmaceuticals, inc.
26
Ani pharmaceuticals, inc.
8
Arrival
12
Aslan pharmaceuticals limited
5
Atea pharmaceuticals, inc.
9
Avadel pharmaceuticals plc
5
Brainstorm cell therapeutics inc.
19
Casi pharmaceuticals, inc.
6
Catalyst pharmaceuticals, inc.
9
Clariant ag
6
Clene inc
32
Cmc materials, inc.
7
Commercial metals company
14
Crinetics pharmaceuticals, inc.
8
Cytokinetics, incorporated
10
Dow inc.
9
Eagle pharmaceuticals, inc.
8
Eli lilly and company
11
Enanta pharmaceuticals, inc.
7
Eyepoint pharmaceuticals, inc.
6
Fusion pharmaceuticals inc.
9
Glaxosmithkline plc
6
Globalstar, inc.
7
Hepion pharmaceuticals, inc.
8
Ionis pharmaceuticals, inc.
12
Johnson & johnson
22
Kalvista pharmaceuticals, inc.
9
Kiora pharmaceuticals inc
6
Medtronic plc
13
Meta materials inc
11
Mp materials corp class a
6
Neurosense therapeutics ltd.
38
Novabay pharmaceuticals, inc.
6
Novartis ag
6
Nrx pharmaceuticals inc
13
Orange
23
Pfizer, inc.
7
Quoin pharmaceuticals ltd - adr
9
Reata pharmaceuticals, inc.
9
Respirerx pharmaceuticals inc.
6
Salarius pharmaceuticals, inc.
9
Sanofi
27
Seelos therapeutics, inc.
6
Spectrum pharmaceuticals, inc.
7
Tff pharmaceuticals, inc.
7
Tonix pharmaceuticals holding corp.
13
Wheaton precious metals corp.
11
X4 pharmaceuticals, inc.
6
Zynerba pharmaceuticals, inc.
9
Symbols
SNY
1
SNYNF
1
TNXP
13
Exchanges
Nasdaq
13
Crawled Date
2022 - 03 - 21
1
2022 - 03 - 14
1
2022 - 03 - 09
1
2022 - 03 - 07
1
2022 - 03 - 03
1
2022 - 02 - 28
1
2022 - 02 - 14
1
2022 - 01 - 06
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 15
1
2021 - 12 - 14
1
2021 - 12 - 13
1
Crawled Time
10:00
1
12:30
3
13:00
1
13:30
1
14:30
1
15:00
1
18:00
1
20:00
1
21:00
1
23:00
2
Source
www.biospace.com
7
www.globenewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Als
entities :
Tonix pharmaceuticals holding corp.
save search
Tonix Pharmaceuticals Announces Phase 3 RALLY Study Results for TNX-102 SL 5.6 mg for the Management of Fibromyalgia
Published:
2022-03-21
(Crawled : 13:00)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-37.54%
|
O:
-6.79%
H:
18.46%
C:
8.4%
tnx-102
als
fibromyalgia
phase 3
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Published:
2022-03-14
(Crawled : 14:30)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-32.78%
|
O:
3.05%
H:
0.0%
C:
-8.62%
als
financial results
report
results
tiona
Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics
Published:
2022-03-09
(Crawled : 23:00)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-33.53%
|
O:
5.32%
H:
1.01%
C:
-2.86%
als
genomics
ces
genomic
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Evaluate TNX-1900 (Intranasal Potentiated Oxytocin) for Treating Binge Eating Disorder
Published:
2022-03-07
(Crawled : 18:00)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-27.58%
|
O:
5.17%
H:
1.06%
C:
-8.08%
tnx-1900
als
order
announces collaboration
collaboration
set
oxytocin
potential
Tonix Pharmaceuticals Announces FDA Orphan-Drug Designation for TNX-2900 for the Treatment of Prader-Willi Syndrome
Published:
2022-03-03
(Crawled : 20:00)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-21.56%
|
O:
46.52%
H:
28.57%
C:
-9.18%
tnx-2900
treatment
fda
als
drug
drug designation
syndros
designation
Tonix Pharmaceuticals Announces Research Agreement with the French National Institute of Health and Medical Research (Inserm) to Study the Mechanism of Oxytocin-Mediated Improvement of Eating Behaviors in Prader-Willi Mice
Published:
2022-02-28
(Crawled : 15:00)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-14.34%
|
O:
1.2%
H:
6.32%
C:
4.4%
health
als
research
media
oxytocin
ism
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference
Published:
2022-02-07
(Crawled : 13:30)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-31.3%
|
O:
4.03%
H:
5.07%
C:
2.51%
als
ceo
conference
Tonix Pharmaceuticals to Participate in Upcoming January 2022 Conferences
Published:
2022-01-05
(Crawled : 10:00)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-63.6%
|
O:
-9.03%
H:
0.0%
C:
0.0%
als
ces
conference
Tonix Pharmaceuticals to Participate in Upcoming January Conferences
Published:
2022-01-05
(Crawled : 12:30)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-63.6%
|
O:
-9.03%
H:
0.0%
C:
0.0%
als
conference
Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines
Published:
2022-01-04
(Crawled : 23:00)
- biospace.com/
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-62.21%
|
O:
3.81%
H:
0.0%
C:
0.0%
als
research
collaboration
vaccine
Tonix Pharmaceuticals Added to the Nasdaq Biotechnology Index
Published:
2021-12-15
(Crawled : 12:30)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-62.99%
|
O:
3.28%
H:
5.19%
C:
4.66%
als
technology
index
biotech
iot
nasdaq
Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Published:
2021-12-14
(Crawled : 12:30)
- globenewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-5.63%
|
O:
-3.62%
H:
0.0%
C:
-0.56%
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-61.01%
|
O:
5.33%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.62%
|
O:
-0.51%
H:
0.0%
C:
0.0%
tnx-2100
als
clearance
skin
cel
sars-cov-2
test
t-cell
Tonix Pharmaceuticals Announces Research Collaboration with Columbia University to Study Recombinant Trefoil Factor 2 (rTFF2)-Based Therapy (TNX-1700) for Gastric and Colorectal Cancers
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-60.84%
|
O:
0.44%
H:
0.0%
C:
0.0%
tnx-1700
als
research
therapy
collaboration
cancer
colorectal cancer
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0366
59.83%
460M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
1.9M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
800K
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.